The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities
Open accessAbstract
The newly discovered endocannabinoid system (ECS; comprising the endogenous lipid mediators endocannabinoids present in virtually all tissues, their G-protein-coupled cannabinoid receptors, biosynthetic pathways and metabolizing enzymes) has been implicated in multiple regulatory functions both in health and disease. Recent studies have intriguingly suggested the existence of a functional ECS in the skin and implicated it in various biological processes (e.g. proliferation, growth, differentiation, apoptosis and cytokine, mediator or hormone production of various cell types of the skin and appendages, such as the hair follicle and sebaceous gland). It seems that the main physiological function of the cutaneous ECS is to constitutively control the proper and well-balanced proliferation, differentiation and survival, as well as immune competence and/or tolerance, of skin cells. The disruption of this delicate balance might facilitate the development of multiple pathological conditions and diseases of the skin (e.g. acne, seborrhea, allergic dermatitis, itch and pain, psoriasis, hair growth disorders, systemic sclerosis and cancer).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Self-citationVanilloid (Capsaicin) Receptors and Mechanisms
Szallasi, A., & Blumberg, P. M. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01403-0 · Cited by 1,903
Control of pain initiation by endogenous cannabinoids
Calignano, A., Rana, G. L., Giuffrida, A., & Piomelli, D. (1998) · Nature · doi:10.1038/28393 · Cited by 1,056
Targeting the endocannabinoid system: to enhance or reduce?
Di Marzo, V. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2553 · Cited by 798
Cannabinoid-based drugs as anti-inflammatory therapeutics
Klein, T. W. (2005) · Nature Reviews Immunology · doi:10.1038/nri1602 · Cited by 728
Cannabinoids: potential anticancer agents
Guzmán, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1188 · Cited by 703
Neuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
Pharmacological Actions of Cannabinoids
Pertwee, R. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_1 · Cited by 597
Enzymatic pathways that regulate endocannabinoid signaling in the nervous system
Ahn, K., McKinney, M. K., & Cravatt, B. F. (2008) · Chemical Reviews · doi:10.1021/cr0782067 · Cited by 529
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521
CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Steinhoff, M., Buddenkotte, J., Shpacovitch, V., Rattenholl, A., Moormann, C., Vergnolle, N., Luger, T. A., & Hollenberg, M. D. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0025 · Cited by 501
Cannabinoid Receptor Signaling
Howlett, A. C. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_2 · Cited by 446
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors
Casanova, M., Blázquez, C., Martínez‐Palacio, J., Villanueva, C., Fernández‐Aceñero, M. J., Huffman, J. W., Jorcano, J. L., & Guzmán, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16116 · Cited by 437
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Mechoulam, R., Fride, E., & Di Marzo, V. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00649-9 · Cited by 428
Ständer, S., Moormann, C., Schumacher, M., Buddenkotte, J., Artuc, M., Shpacovitch, V., Brzoska, T., Lippert, U., Henz, B. M., Luger, T. A., et al. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.0178.x · Cited by 411
Frontiers in pruritus research: scratching the brain for more effective itch therapy
Paus, R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28553 · Cited by 373
Self-citationNeuroimmunoendocrine circuitry of the ‘brain-skin connection’
Paus, R., Theoharides, T. C., & Arck, P. C. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.10.002 · Cited by 343
Self-citationAttenuation of Allergic Contact Dermatitis Through the Endocannabinoid System
Karsak, M., Gaffal, E., Date, R., Wang-Eckhardt, L., Rehnelt, J., Petrosino, S., Starowicz, K., Steuder, R., Schlicker, E., Cravatt, B., et al. (2007) · Science · doi:10.1126/science.1142265 · Cited by 338
Endocannabinoids: synthesis and degradation
Di Marzo, V. (2006) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_0505 · Cited by 311
Multiple pathways involved in the biosynthesis of anandamide
Liu, J., Wang, L., Harvey-White, J., Huang, B. X., Kim, H.-Y., Luquet, S., Palmiter, R. D., Krystal, G., Rai, R., Mahadevan, A., et al. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.020 · Cited by 304
Ständer, S., Schmelz, M., Metze, D., Luger, T., & Rukwied, R. (2005) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2005.01.007 · Cited by 298
Cannabinoid receptors as novel targets for the treatment of melanoma
Blázquez, C., Carracedo, A., Barrado, L., José Real, P., Luis Fernández‐Luna, J., Velasco, G., Malumbres, M., Guzmán, M., Blázquez, C., Carracedo, A., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-6638fje · Cited by 292
Costa, B., Comelli, F., Bettoni, I., Colleoni, M., & Giagnoni, G. (2008) · Pain · doi:10.1016/j.pain.2008.06.003 · Cited by 286
A historical overview of chemical research on cannabinoids
Mechoulam, R., & Hanuš, L. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00184-5 · Cited by 282
The endocannabinoid system in obesity and type 2 diabetes
Di Marzo, V. (2008) · Diabetologia · doi:10.1007/s00125-008-1048-2 · Cited by 281
Cannabinoids for Cancer Treatment: Progress and Promise
Sarfaraz, S., Adhami, V. M., Syed, D. N., Afaq, F., & Mukhtar, H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2785 · Cited by 275
Cannabidiol—transdermal delivery and anti-inflammatory effect in a murine model
Lodzki, M., Godin, B., Rakou, L., Mechoulam, R., Gallily, R., & Touitou, E. (2003) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.09.001 · Cited by 268
Neurophysiological, Neuroimmunological, and Neuroendocrine Basis of Pruritus
Steinhoff, M., Bienenstock, J., Schmelz, M., Maurer, M., Wei, E., & Bíró, T. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700231 · Cited by 265
Self-citationWright, K. L., Duncan, M., & Sharkey, K. A. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707486 · Cited by 264
The search for the palmitoylethanolamide receptor
LoVerme, J., La Rana, G., Russo, R., Calignano, A., & Piomelli, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.012 · Cited by 248
Immunoreactivity of VR1 on Epidermal Keratinocyte of Human Skin
Denda, M., Fuziwara, S., Inoue, K., Denda, S., Akamatsu, H., Tomitaka, A., & Matsunaga, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5299 · Cited by 226
Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Pacher, P., & Haskó, G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707582 · Cited by 217
Self-citationMarzo, V. D., Melck, D. J., Orlando, P., Bisogno, T., Zagoory, O., Bifulco, M., Vogel, Z., & PETROCELLIS, L. D. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3580249 · Cited by 212
Wilkinson, J. D., & Williamson, E. M. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2006.10.009 · Cited by 212
Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 203
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects
Izzo, A. A., & Camilleri, M. (2008) · Gut · doi:10.1136/gut.2008.148791 · Cited by 199
A Hot New Twist to Hair Biology
Bodó, E., Bíró, T., Telek, A., Czifra, G., Griger, Z., Tóth, B. I., Mescalchin, A., Ito, T., Bettermann, A., Kovács, L., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62320-6 · Cited by 193
Self-citationThe endocannabinoid system in targeting inflammatory neurodegenerative diseases
Centonze, D., Finazzi-Agrò, A., Bernardi, G., & Maccarrone, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.02.004 · Cited by 182
Cannabinoid Mechanisms of Pain Suppression
Walker, J. M., & Hohmann, A. G. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_17 · Cited by 176
The Endocannabinoid System in Human Keratinocytes
Maccarrone, M., Di Rienzo, M., Battista, N., Gasperi, V., Guerrieri, P., Rossi, A., & Finazzi-Agrò, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303994200 · Cited by 166
Interactions of the Skin and Nervous System
Ansel, J. C., Armstrong, C. A., Song, I., Quinlan, K. L., Olerud, J. E., Caughman, S. W., & Bunnett, N. W. (1997) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1038/jidsymp.1997.6 · Cited by 158
Endocannabinoids and Neuroprotection
Mechoulam, R., Spatz, M., & Shohami, E. (2002) · Science Signaling · doi:10.1126/stke.2002.129.re5 · Cited by 151
Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain
Jhaveri, M. D., Richardson, D. S., & Chapman, V. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707433 · Cited by 147
Dobrosi, N., Tóth, B. I., Nagy, G., Dózsa, A., Géczy, T., Nagy, L., Zouboulis, C. C., Paus, R., Kovács, L., & Bíró, T. (2008) · The FASEB Journal · doi:10.1096/fj.07-104877 · Cited by 142
Self-citationNeuromediators—a crucial component of the skin immune system
Luger, T. A. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(02)00103-2 · Cited by 135
Dysregulation of the Endocannabinoid System in Obesity
Engeli, S. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01683.x · Cited by 134
The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
Akhmetshina, A., Dees, C., Busch, N., Beer, J., Sarter, K., Zwerina, J., Zimmer, A., Distler, O., Schett, G. A., & Distler, J. H. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24395 · Cited by 133
Pacher, P., Mukhopadhyay, P., Rajesh, M., Godlewski, G., Bátkai, S., & Kunos, G. (2008) · Hypertension · doi:10.1161/hypertensionaha.105.063651 · Cited by 123
Self-citationInhibition of human hair follicle growth by endo‐and exocannabinoids
Telek, A., Bíró, T., Bodó, E., Tóth, B. I., Borbíró, I., Kunos, G., & Paus, R. (2007) · The FASEB Journal · doi:10.1096/fj.06-7689com · Cited by 115
Self-citationEndocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Mallat, A., & Lotersztajn, S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2007 · Cited by 113
Paradisi, A., Pasquariello, N., Barcaroli, D., & Maccarrone, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707964200 · Cited by 112
Ständer, S., Reinhardt, H., & Luger, T. A. (2006) · Der Hautarzt · doi:10.1007/s00105-006-1180-1 · Cited by 111
Oka, S., 潤一, 和., Ikeda, S., Shin, Y., Kishimoto, S., Gokoh, M., Nasui, M., & Sugiura, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8796 · Cited by 109
Zheng, D., Bode, A. M., Zhao, Q. J., Cho, Y., Zhu, F., Ma, W.-Y., & Dong, Z. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6594 · Cited by 98
Stress-induced generation of N-acylethanolamines in mouse epidermal JB6 P+ cells
Berdyshev, E. V., Schmid, P. C., Dong, Z., & Schmid, H. H. O. (2000) · Biochemical Journal · doi:10.1042/bj3460369 · Cited by 97
Carbonare, M. D., Giudice, E. D., Stecca, A., Colavito, D., Fabris, M., D'Arrigo, A. M., Bernardini, D., Dam, M., & Leon, A. A. G. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01689.x · Cited by 87
Tóth, B. I., Benkő, S., Szöllősi, A. G., Kovács, L., Rajnavölgyi, É., & Bı́ró, T. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.04.031 · Cited by 86
Self-citationCannabinoid receptors in acute and chronic complications of atherosclerosis
Mach, F., Montecucco, F., & Steffens, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707517 · Cited by 78
Ueda, Y., Miyagawa, N., Matsui, T., Kaya, T., & IWAMURA, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.013 · Cited by 67
Cannabinoids for the treatment of neuropathic pain: clinical evidence.
Ashton, J. C., & Milligan, E. D. (2008) · PubMed · Cited by 60
Pulvirenti, N., Nasca, M. R., & Micali, G. (2007) · PubMed · Cited by 60
The Endocannabinoid System and Multiple Sclerosis
Baker, D., & Pryce, G. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740036 · Cited by 54
Pacher, P., & Gao, B. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00523.2007 · Cited by 52
Self-citationTransdermal Delivery of the Synthetic Cannabinoid WIN 55,212-2: In Vitro/in Vivo Correlation
Valiveti, S., Hammell, D. C., Earles, D. C., et al. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000032999.31948.2e · Cited by 36
Srivastava, B. K., Soni, R., Patel, J. Z., Joharapurkar, A. A., Sadhwani, N., Kshirsagar, S. G., Mishra, B. A., Takale, V., Gupta, S. V., Pandya, P., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.046 · Cited by 27
Involvement of cannabinoid CB2 receptors in the IgE-mediated triphasic cutaneous reaction in mice
Ueda, Y., Miyagawa, N., & Wakitani, K. (2006) · Life Sciences · doi:10.1016/j.lfs.2006.09.026 · Cited by 24
Allergic Contact Dermatitis and the Endocannabinoid System: From Mechanisms to Skin Care
Lambert, D. M. (2007) · ChemMedChem · doi:10.1002/cmdc.200700168 · Cited by 17
Cited by
Endocannabinoid signaling at the periphery: 50 years after THC
Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., Konje, J. C., Kunos, G., Mechoulam, R., Pacher, P., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.02.008 · Cited by 646
Self-citationSlominski, A. T., Zmijewski, M. A., Skobowiat, C., Zbytek, B., Slominski, R. M., & Steketee, J. D. (2012) · Advances in Anatomy, Embryology and Cell Biology · doi:10.1007/978-3-642-19683-6 · Cited by 496
Ligresti, A., De Petrocellis, L., & Di Marzo, V. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 469
Slominski (2012) · doi:10.1007/978-3-642-19683-6_1 · Cited by 461
How UV Light Touches the Brain and Endocrine System Through Skin, and Why
Slominski, A. T., Zmijewski, M. A., Plonka, P. M., Szaflarski, J. P., & Paus, R. (2018) · Endocrinology · doi:10.1210/en.2017-03230 · Cited by 452
Self-citation
Metadata
- Authors
- Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 30
- Issue
- 8
- Pages
- 411-420
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2131589396
- Cited by
- 271
- References
- 71
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.